11/07/2024 6:03 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:05 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/08/2024 5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form SC 13D/A | |
10/08/2024 5:50 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) LAMPERT MARK N (Reporting) MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:30 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:02 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:04 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
06/10/2024 4:06 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) LAMPERT MARK N (Reporting) MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:40 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 6:30 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:01 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:02 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024 6:57 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-K/A | |
04/24/2024 3:30 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form DEF 14A | |
04/24/2024 3:31 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:33 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form ARS | |
03/11/2024 7:01 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 6:53 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Reich Kristian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:56 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Santos da Silva Jorge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 7:03 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:05 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/26/2024 8:00 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 5:32 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Reich Kristian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 5:36 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Santos da Silva Jorge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 5:02 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Reich Kristian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 7:00 AM | Merck Healthcare KGaA (Filed by) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 3:57 PM | CITADEL ADVISORS LLC (Filed by) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:28 AM | FMR LLC (Filed by) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form SC 13G | |
12/20/2023 3:16 PM | Bodenstedt Matthias (Reporting) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023 3:34 PM | Bodenstedt Matthias (Reporting) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |